Hypophosphatasia Market Overview
The National Organisation for Rare Disorders (NORD) defines hypophosphatasia as a rare, hereditary metabolic condition characterised by poor mineralization of bones and teeth. Defective mineralization causes fragile, fracture-prone, and deformed bones, which also result in tooth loss. It can be inherited autosomally recessively or dominantly, depending on the specific form.
&nbsp;
<a style="background-color: transparent; color: #1155cc;" href="https://www.delveinsight.com/report-store/hypophosphatasia-epidemiology-forecast" target="_blank" rel="noopener noreferrer">Hypophosphatasia Epidemiology</a> Insights (2021)
The Total Hypophosphatasia Diagnosed Prevalent Cases in the 7MM were 6,497 cases in 2021
&nbsp;
Severity-specific Diagnosed Prevalent Cases in the US
<ul>
<li>Mild - 4,914</li>
<li>Moderate - 995</li>
<li>Severe - 121</li>
</ul>
&nbsp;
Hypophosphatasia Epidemiology Segmentation in the 7MM from 2019 to 2032
<ul>
<li>Diagnosed Prevalent Cases</li>
<li>Severity-specific Diagnosed Prevalent Cases</li>
</ul>
&nbsp;
<a style="background-color: transparent; color: #1155cc;" href="https://www.delveinsight.com/report-store/hypophosphatasia-market" target="_blank" rel="noopener noreferrer">Hypophosphatasia Market</a> Insight (2021)
The Hypophosphatasia Market size in the 7MM was valued USD 677.8 million in 2021
&nbsp;
Hypophosphatasia Market Strengths
<ul>
<li>Advancements in understanding the pathophysiology and genetics of Hypophosphatasia, thereby elucidating new targets for treatment.</li>
</ul>
&nbsp;
Hypophosphatasia Market Opportunities
<ul>
<li>Developing specific biochemical biomarker-based assays with an increased understanding of differential diagnosis among physicians will lead to improvements in diagnosis, thus opening the windows of opportunity for new treatment options.</li>
</ul>
&nbsp;
Hypophosphatasia Emerging Drugs and Key Companies
<ul>
<li>REC-01: PuREC</li>
<li>ALXN1850: AstraZeneca</li>
<li>ARU-2801: Aruvant Sciences</li>
<li>recAP: AM-Pharma</li>
<li>ENPP1 inhibitor: Rallybio/ Exscientia, and others</li>
</ul>

Hypophosphatasia Market 

Hypophosphatasia Market Infographics 

Hypophosphatasia Market  Symptoms, Treatment, epidemiology, companies, drugs, infographic is a short guide to understand the problem and market landscape